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INTRODUCTION 
Coronary flow reserve (CFR) is a powerful marker of the myocardial 
capacity to adapt blood supply to an increased myocardial work (1). A 
reduction CFR reflects not only the presence of coronary artery stenosis 
but also coronary vascular dysfunction (2).  
Epicardial adipose tissue (EAT) defined as the adipose tissue located 
between the myocardium and pericardium, is the visceral fat storehouse 
of the heart and it is a metabolically active organ that generates a variety 
of bioactive molecules, which could significantly affect cardiac 
function (3). Indeed, EAT coats the coronary arteries without any 
intervening fascial barrier, thus sharing the same perfusion of the heart 
(4). The close anatomic relationship of epicardial adipose tissue to the 
adjacent myocardium may imply paracrine regulation by this small fat 
depot, although the relationship could not exclude also a systemic 
control (3).  
Moreover, compared to other fat depots, EAT shows own unique 
characteristics such as higher density of smaller adipocytes suggesting 
specific metabolic properties with a greater rate of release of free fatty 
acids (5,6).  
In addition, it has been demonstrated that EAT correlates with cardiac 
sympathetic denervation and it represents a source of catecholamine 
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production suggesting a potential role of EAT in cardiac response to 
sympathetic stimuli (7).  
More recently, literature has proved that fat quantification may have 
prognostic implications in prediction of adverse cardiovascular events 
(8, 9). Despite a few evidences of a direct correlation between increased 
EAT and impaired CFR in small patients’ population with suspected or 
known coronary artery disease (CAD) (10-12), the association between 
EAT and CFR parameters remains to be fully investigated.  
  
6 
 
AIM OF THE STUDY 
We aimed to investigate the relationship between EAT and CFR in 
patients with suspected or known CAD referred to stress-rest 82Rb 
PET/CT imaging showing normal myocardial perfusion imaging (MPI). 
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METHODS 
Patients 
For the purpose of the present investigation, we considered consecutive 
patients with normal stress-rest 82Rb PET/CT perfusion selected from 
those referred to our Institution (Department of Advanced Biomedical 
Sciences, University Federico II, Naples, Italy) from December 2013 to 
June 2017 for the evaluation of suspected or known CAD as part of their 
diagnostic and treatment monitoring program. 
As part of the baseline examination, clinical teams collected 
information on traditional cardiovascular risk factors including age, 
sex, hypertension, diabetes, hypercholesterolemia, smoking, family 
history of CAD, chest pain symptoms, and documented history of 
myocardial infarction and revascularization procedures 
Hypertension was defined as a blood pressure >140/90 mmHg or the 
use of anti-hypertensive medication (13). Patients were classified as 
having diabetes if they were receiving treatment with oral 
hypoglycaemic drugs or insulin. Hypercholesterolemia was defined as 
total cholesterol level > 6.2 mmol/L or treatment with cholesterol 
lowering medication. A positive family history of CAD was defined by 
the presence of disease in first-degree relatives younger than 55 years 
in men or 65 years in women. Patients with atrial fibrillation, pacemaker 
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or prosthetic valve, severe loss of renal function, symptomatic asthma, 
and pregnancy were excluded.  
The review committee of our institution approved the study, and all 
patients gave informed consent to the protocol. 
PET/CT imaging protocol 
As a routine preparation for 82Rb cardiac PET/CT, patients were asked 
to discontinue taking nitrates for 6 hours, calcium channel blockers and 
caffeine-containing beverages for 24 hours, and b-blockers for 48 hours 
before their appointment.  
Scans were acquired using a Discovery LS scanner (GE). Rest and 
stress cardiac PET/CT images were acquired as follows (14). Following 
a CT scout acquisition (120 kVp, 10 mA) for patient positioning, a CT 
transmission scan was acquired (140 kVp, 80 mA) for subsequent 
attenuation correction and for CAC scoring and EAT quantification. 
Rest and stress CT transmission scans were acquired at end-expiration 
breath-hold, and patients were instructed to breath normally during the 
PET acquisition. For both rest and stress, imaging 1110 MBq of 82Rb 
was injected intravenously and a 6-min PET study was acquired. 
Pharmacologic stress was then induced by administration of 
dipyridamole (0.142 mg/kg/min for 4 min). Both rest and stress 
dynamic images were reconstructed into 20 time frames (12 × 8 s, 5 × 
12 s, 1 × 30 s, 1 × 60 s and 1 × 60 s) using attenuation-weighted ordered-
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subsets expectation maximization (two iterations, 24 subsets). CT-
based attenuation, scatter, decay, and random corrections were applied 
to the reconstructed images. The heart rate, systemic blood pressure, 
and 12- lead ECG were recorded at baseline and throughout the infusion 
of dipyridamole. The rate–pressure product was calculated as heart rate 
multiplied by systolic blood pressure. Transaxial PET perfusion images 
were automatically reoriented into short-axis and vertical and 
horizontal long axis slices Regional myocardial perfusion was visually 
assessed, using standardized segmentation of 17 myocardial regions. 
Each myocardial segment was scored from normal (score = 0) to absent 
perfusion (score = 4). The summed stress score was obtained by adding 
the scores of the 17 segments of the stress images. A similar procedure 
was applied to the resting images to calculate the summed rest score 
and summed difference score was the difference between the stress and 
rest scores. Myocardial perfusion was considered abnormal when the 
summed stress score was ≥3 (15). Absolute MBF (in ml/min/gr) was 
computed from the dynamic rest and stress imaging series with 
commercially available software (Flow Quant, University of Ottawa 
Heart Institute). CFR was defined as the ratio of hyperaemic to baseline 
MBF and it was considered reduced when <2 (16). rate-pressure-
product (RPP)-corrected CFR was calculated using baseline MBF 
corrected for RPP. 
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Coronary calcium score 
For CAC scoring, rest CT axial reconstructions were transferred to a 
dedicated workstation (Vitrea Workstation, Toshiba Medical Systems, 
Tokyo, Japan) for post processing and subsequent analysis. Coronary 
calcification was defined as a plaque with an area of 1.03 mm2 and a 
density ≥130 HU. CAC scores were calculated according to the method 
described by Agatston et al. (17). Experienced nuclear medicine 
physicians and radiologists analysed the CT studies, blinded to the PET 
results. CAC scores were calculated separately for calculated separately 
for the for the common trunk, left anterior descending, left circumflex 
and right coronary arteries and summed to provide a total CAC score. 
Epicardial Adipose Tissue quantification  
Epicardial adipose tissue (EAT) volume was quantified on non-contrast 
CT images, by Osirix software. The image processing started at the 
level of the pulmonary trunk and ended at the level of the inferior 
diaphragmatic surface of the heart to manually trace pericardial borders. 
The area outside the traced pericardium was excluded. 
The range of attenuation for EAT segmentation was then set between 
−30 and −190 HU.  This effectively excluded myocardium, coronary 
arteries, coronary calcium, the aorta, and blood pool as shown. Finally, 
images were checked and reviewed by operators to correct potential 
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errors and total EAT volume was calculated (18, 19). On unenhanced 
CT images, EAT thickness (mm) measurements were also performed 
along the right ventricular anterior free wall in a single sagittal slice 
having the greatest EAT thickness (12). 
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 Statistical Analysis 
Continuous variables are expressed as mean ± standard deviation (SD) 
and compared by the use of unpaired t-test. CAC scores and EAT 
volume were adjusted using the ln (CAC + 1) and ln (EAT) 
transformations to reduce the rightward skewness of the data and 
heteroscedasticity respectively. 
Categorical variables are expressed as proportion and compared by use 
of chi-square test.  
Patients were divided in to three groups according to tertile of EAT low-
tertile (<86 cm3); middle-tertile (≥86 cm3 and <124 cm3) and high-tertile 
(≥124 cm3) respectively. Differences in hyperemic MBF and CFR 
across levels of EAT categories were assessed using ANOVA.  A P 
value <0.05 was considered statistically significant. 
Univariable and multivariable linear regression analyses were 
performed to examine the relationship between age, gender, cardiac risk 
factors, ln (CAC + 1) score, ln (EAT) volume and hyperemic MBF and 
CFR. We considered for the multivariable analysis only variables 
statistically significant at univariable analysis. 
Univariable and multivariable logistic regression analyses were also 
performed to identify the variables associated with a reduced CFR.  
The incremental value of imaging findings over clinical data in 
predicting reduced CFR was assessed considering variables in 
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hierarchical order. A P value <0.05 was considered statistically 
significant. Finally, the relationship between of EAT volume and CFR 
was evaluated by using Pearson coefficient. 
All the analyses were performed using STATA version 14.0 for 
Windows (StataCorp LP, College Station, TX). 
  
14 
 
RESULTS 
Between December 2013 to June 2017, 510 patients with suspected or 
known CAD were referred to our Institution to perform stress-rest 82Rb 
cardiac PET/CT for the evaluation of suspected or known CAD as part 
of their diagnostic program.  From the overall population, 240 patients 
showed abnormal perfusion and therefore they were excluded from the 
final analysis. 
Baseline characteristics of the final population are described in Table 1. 
As illustrated, among 270 patients with normal MPI, 93 (35%) patients 
showed reduced CFR and 177 (65%) normal CFR. Compared to patients 
with normal CFR, those with impaired CFR were older (P<0.05). No 
other clinical differences were observed.  
Imaging findings in the overall population are described in Table 2. 
Compared to patients with normal CFR, those with impaired CFR 
showed higher values of ln (CAC+1), P<0.05), EAT thickness (P<0.01) 
and ln (EAT) volume (P<0.001).  Patients with reduced CFR did not 
show statistical difference of baseline MBF mean values as compared 
to those with normal CFR. However, they demonstrated a blunted 
response to pharmacological stressor (P <0.001). 
Linear regression analyses considering hyperemic MBF as dependent 
variable are shown in Table 3. As shown, while age, sex, diabetes, 
hyperlipidemia, ln (CAC+1) and ln (EAT) volume were significantly 
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associated with hyperemic MBF at univariable analysis, at multivariable 
analysis only sex and ln (EAT) volume were inversely related with 
hyperemic MBF ( coefficient: -0.337 and -0.221; standard error 0.091 
and 0.088; respectively, all P<0.005). 
 
The results of logistic regression analyses with reduced CFR as 
dependent variable are depicted in Table 4. As presented, although age, 
ln (CAC+1) and ln (EAT) volume resulted significant predictors of 
reduced CFR, at multivariable analysis, only age and ln (EAT) volume 
were independently associated with reduced CFR (hazard ratio 1.055 
and 1.913 and 95% confidence interval 1.025-1.086 and 1.021-3.585 
respectively, all P<0.005).  
Interestingly, although body mass index (BMI) was significantly related 
to ln (EAT) volume (r= 0.192 P value <0.005), this parameter did not 
result a predictor neither of CFR nor of hyperemic MBF.  
Accordingly, at incremental analysis, while a model including clinical 
data and ln (CAC+1) score did not show significant difference as 
compared to a model including only clinical data (global chi-square 
from 23.3 to 23.5, P=0.65), the addition of ln (EAT) volume to clinical 
data significantly increased the global chi-square of the model (from 
23.3 to 28.5, P<0.05) demonstrating incremental power of EAT in 
predicting reduced CFR (Figure 1).  
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To test the relationship of EAT with CFR and with hyperemic MBF, 
patients were divided in to three groups according to tertile of EAT: 
low-tertile (n= 90); middle-tertile (n= 90) and high-tertile (n= 90) 
respectively and global hyperemic MBF and CFR scatter plots in 
relation to EAT tertile groups are illustrated in Figure 2.  As shown both 
global hyperemic MBF (2A) and CFR (2B) decreased with increasing 
EAT amount (P value for trend <0.05 in 2A and <0.001 in 2B). 
In addition, to assess a potential correlation between CAC score and 
EAT, patients were considered according to evidence of measurable 
CAC. The correlation of EAT volume and CFR in relation to 
documented CAC is represented in Figure 3. As shown, a significant 
correlation was observed between ln (EAT) volume and CFR (r= −.229, 
P value <0.05) in patients with CAC score =0 (n=114) while such a 
relationship was not significant in patients with documented CAC 
(n=156) (r= −.101, P value N.S.) suggesting that EAT may have a 
stronger role in predicting reduced CFR in patients without coronary 
artery calcium load.  
Representative examples of similar age patients with normal MPI and 
different EAT volume values according to CFR results are depicted in 
Figure 4.  
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DISCUSSION 
It has been demonstrated that CFR provides independent prognostic 
power for outcome prediction in patients with suspected and known 
CAD (1,20). Therefore, there is great interest in early identification of 
reliable markers of impaired CFR. To our knowledge, this is the first 
study investigating the relationship between not only CFR but also 
hyperemic MBF and EAT in a large population of patients with 
suspected and known CAD and normal MPI.  
The studied population only included patients with normal MPI. Indeed, 
we hypothesized that a potential relationship of EAT and coronary 
vascular function may have stronger diagnostic implications at initial 
stage of coronary vascular impairment, allowing early therapeutic 
interventions. 
In our population, CFR and hyperemic MBF were independently 
associated with  
the two unchangeable cardiac risk factors, by means age and sex, and 
with ln(EAT) volume. However, this latter variable demonstrates 
incremental power in predicting coronary vascular dysfunction over 
clinical data and documented coronary calcium burden.  
Cardiac fat depot can be measured with different modalities and 
parameters. While the evaluation of EAT thickness on 
echocardiography shows good reproducibility but it is affected by the 
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lack of information about the total epicardial fat load, cardiac CT and 
magnetic resonance, allow more accurate volumetric quantification 
with higher reproducibility (21).  Therefore, although both ln (EAT) 
volume and EAT thickness resulted predictors of reduced CFR and 
hyperemic MBF, we only included ln (EAT) volume in multivariable 
models. 
Our findings are substantially in agreement with few previous studies 
including smaller populations with different clinical characteristics 
(10,12).  
Otaki and coworkers (9) demonstrated that EAT volume is a significant 
predictor of reduced CFR in a population of 85 patients with suspected 
CAD referred to invasive coronary angiography on the basis of stress-
rest cardiac 82RB PET/CT perfusion results. Moreover, Alam et al (12) 
found, in a smaller cohort of patients only without obstructive CAD and 
normal MPI, an inverse relationship between EAT thickness and CFR  
Our results, obtained in a larger size population, may suggest to extend 
clinical investigations regarding both CFR and hyperemic MBF from 
patients with suspected CAD and abnormal perfusion to those with 
suspected or known CAD and normal MPI.  
Noteworthy, in our study, even if CAC score resulted a predictor of 
reduced CFR, in a multivariable model including clinical data and EAT 
volume, it did not show an independent association with impaired 
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coronary vascular function. As described, while a significant correlation 
was observed between ln (EAT) volume and CFR in patients without 
coronary calcium, such a relationship was not significant in patients 
with documented CAC suggesting that EAT may contribute to 
development of coronary vascular dysfunction before coronary artery 
calcium accumulation.  
The emerging concept that EAT evaluation may have not only a role in 
identification of reduced CFR but it could also be considered a 
prognostic tool and a therapeutic target, has been supported by recent 
literature (8,22-24). Indeed, different studies highlighted the potential 
interplay between inflammatory stimuli released from epicardial 
adipose tissue and CFR before clinical manifestations of CAD (22-28).  
Recently, Goeller et al (22) found that increased EAT volume was 
associated with presence of coronary calcification, serum levels of 
plaque inflammatory markers as well as with major cardiac events, 
suggesting that dysfunctional EAT may be linked to early plaque 
development inflammation and adverse cardiac outcome regardless to 
coronary calcium evidence. A positive correlation between EAT 
volume index, the degree of myocardial fibrosis, and LV systolic 
function impairment was also found in 40 volunteers without diabetes 
mellitus or hypertension (29).  
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Interestingly, we found that although BMI was significantly related with 
EAT volume, it was not associated with CFR. Similarly, Ding et al. (25) 
found that neither BMI nor waist circumference were associated with 
calcified coronary plaque despite their being significantly correlated 
with fat depot.  Whilst, Taguchi and coworkers (28) observed that 
pericardial fat accumulation is more closely associated with CAD 
morbidity than any other body fat distribution.  Thus, our results in 
agreement with previous studies (27-30), support the growing idea that 
anthropometric measures of adiposity such as BMI and body surface 
area (BSA) may not fully reflect the cardiovascular risk associated to 
obesity. 
As previously suggested by Iacobellis et al. (31), the contiguity of EAT 
to the myocardium and coronary arteries, allows local paracrine 
interactions, rendering EAT most likely a stronger correlate to left 
ventricular (LV) mass than general measures of adiposity such as BMI. 
Furthermore, there is growing evidence that EAT is a metabolically 
active organ and an important source of pro- and anti-inflammatory 
mediators and cytokines (32) such as tumour necrosis factor-α, leptin 
and interleukins 6 and 17, which are believed to exert local effects on 
the underlying coronaries and myocardium. Indeed, these inflammatory 
markers have been implicated in the pathogenesis of LV remodelling 
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and further highlight the importance of EAT as an important and early 
marker for cardiovascular risk. 
Therefore, in the light of large body literature and according to our 
results, the perspective of specifically targeting the cardiac fat depot for 
more effective CAD prevention seems very promising. 
It remains to be estabilished whether any changes in EAT profile 
could be the result, rather than the cause, of underlying cardiac 
disease. Indeed, as suggested by Antonopoulos et al. (33) a reverse 
(inside-out) signaling from the heart to EAT may lead to changes in 
the EAT phenotype and secretory profile to protect the heart from 
oxidative damage. Therefore, a deeper understanding of cardiac fat 
role as heart caretaker rather than cardiac damage trigger could have 
strong therapeutic impact.  
Some limitations of our study should be acknowledged. First, our 
study was a single center investigation. 
Moreover, 38% of studied patients have history of previous 
revascularization.  This characteristic could represent a limitation in the 
assessment of relation between coronary calcium burden and EAT for 
the understanding of different contribution of each variable in the 
coronary vascular dysfunction development. However, as described, a 
significant correlation was observed between ln (EAT) volume and CFR 
22 
 
in patients without evidence of coronary calcium, suggesting that EAT 
may have a stronger role in coronary vascular dysfunction onset before 
coronary artery calcium accumulation.  
Yet, it has been demonstrated that not only the EAT volume but also 
the EAT density has prognostic implication in prediction of cardiac 
events (22). Though, EAT density data were not available for the 
studied population. Therefore, in further studies it could be interesting 
to investigate the relationship of EAT density and coronary vascular 
function, as well as outcome.  
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CONCLUSION 
In patients with suspected or known CAD and normal MPI EAT is 
strongly associated with reduced CFR and hyperemic MBF confirming 
that visceral fat depot may directly influence coronary vascular 
function. 
Thus, EAT evaluation may play a major role in the identification of 
coronary vascular dysfunction even in patients with normal MPI. In 
particular, it could be useful to consider EAT in patients with to no 
evidence of coronary calcium burden. 
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FIGURE LEGEND 
Figure 1 Incremental analysis for prediction of reduced coronary flow 
reserve (CFR). A model including clinical data and ln (CAC+1) score 
did not show significant difference as compared to a model including 
only clinical data (global chi-square from 23.3 to 23.5, P=0.65) did not 
show. Conversely the addition of ln (EAT) volume to clinical data 
significantly increased the global chi-square of the model (from 23.3 to 
28.5, P<0.05). 
Figure 2 Global hyperemic myocardial blood flow (MBF) (A) and 
coronary flow reserve (CFR) (2B) scatter plots in relation to epicardial 
adipose tissue (EAT) tertile groups (P for trend <0.05 in A and <0.001 
in B). 
Figure 3 Correlation between ln (EAT) volume and coronary flow 
reserve (CFR) values in patients with CAC score =0 (dark navy dots 
and line), (r= −0.229, P<0.05) and in patients with CAC score > 0 
(maroon dots and line), (r= −0.101 P=N.S.). 
Figure 4 Representative examples of patients with similar age and 
normal MPI with different EAT volume values according to CFR 
results. The patient described in panel A shows low EAT volume and 
normal CFR. Conversely, as illustrated in panel B, high values of EAT 
volume were consistent with reduced CFR. 
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Table 1  
Baseline characteristics of patients according to CFR results   
  All Patients 
(n=270) 
Reduced 
CFR 
(n=93) 
Normal 
CFR 
(n=177) 
P value 
Age (years) 62.31±11.1 66.66±9.1 60.03±11.4 <0.001 
Male gender, n (%) 188 (69) 66 (71) 121 (68) 0.659 
Body mass index (kg/m2 ) 28.22±5.8 28.76±4.3 27.94±6.3 0.266 
Diabetes, n (%) 77 (29) 27 (29) 50 (28) 0.892 
Hypertension, n (%) 231 (86) 81 (87) 150 (85) 0.602 
Hypercholesterolemia, n (%) 192 (71) 72 (77) 120 (68) 0.097 
Smoking history, n (%) 121 (45) 40 (43) 81 (46) 0.666 
Family history of CAD, n (%) 149 (55) 56 (60) 93 (53) 0.228 
Previous revascularization, n (%) 104 (38) 40 (43) 64 (36) 0.272 
Previous myocardial infarction, n (%) 75 (28) 26 (27) 49 (28) 0.962 
Values are expressed as mean value ± standard deviation or as number 
(percentage) of subjects. CFR: coronary flow reserve; CAD: coronary artery 
disease. 
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Table 2  
Imaging test results according to CFR results   
  All Patients 
(n=270) 
Reduced 
CFR 
(n=93) 
Normal 
CFR 
(n=177) 
P value 
ln (CAC+1) 4.15±2.98 4.67±2.94 3.88±2.97 <0.05 
EAT thickness (mm) 6.14±2.24 6.63±2.39 5.89±2.12 <0.01 
ln (EAT) volume 4.60±0.48 4.73±0.41 4.52±0.50 <0.001 
Rest MBF (mL/min/g) 0.79 ±0.26 0.83±0.30 0.78±0.24 0.063 
Hyperemic MBF (mL/min/g) 1.81±0.69 1.29±0.53 2.08±0.61 <0.001 
Values are expressed as mean value ± standard deviation or as number 
(percentage) of subjects. CFR: coronary flow reserve; CAD: coronary artery 
disease; EAT: epicardial adipose tissue; MBF: myocardial blood flow 
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Table 3 
Linear regression analyses with hyperaemic MBF as dependent variable 
 Univariable analysis Multivariable analysis 
 b coefficient      SE P value b coefficient      SE P value 
Age   -.012            .002 .004       -.004                .004 .235      
Male gender  -.442            .088      .000  -.337                .091 .000     
Body mass index  -.011            .007      .132   
Diabetes  -.195            .093       .036  -.058                .091 .526    
Hypertension   .006            .120       .957   
Hypercholesterolemia -.239             .092       .010  -.116                .091 .206     
Smoking history -.102             .073       .232   
Family history of CAD .091              .085        .286   
Previous revascularization -.155             .086       .074   
Previous myocardial infarction -.078             .094      .407   
ln (CAC+1) -.054             .014      .000  -.018                .015 .235      
EAT thickness  -.054             .019       .004   
ln EAT volume -.359             .085       .000                     -.221               .088 .013  
SE: standard error; MBF: myocardial blood flow; CAD: coronary artery disease; 
CAC: coronary artery calcium EAT: epicardial adipose tissue;  
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Table 4 
 Logistic regression analyses with reduced CFR as dependent variable 
 Univariable analysis Multivariable analysis 
 Hazard ratio 
(95% CI) 
P value Hazard ratio 
(95% CI) 
P value 
Age  1.064 (1.036-1.093) <0.001 1.055 (1.025-1.086) <0.001 
Male gender 0.884 (511.-1.530) 0.659   
Body mass index  1.025 (.980-1.071) 0.288   
Diabetes 1.039 (.597-1.809) 0.893   
Hypertension 1.215 (.585-2.526) 0.602   
Hypercholesterolemia 1.629 (.912-2.907) 0.099   
Smoking history .894 (.539-1.484) 0.666   
Family history of CAD 1.367(.821-2.275) 0.229   
Previous revascularization 1.333 (.798-2.224) 0.272   
Previous myocardial infarction 1.205(.725-2.004) 0.472   
ln (CAC+1) 1.094(1.004-1.191) 0.039 1.012 (.921-1.112) 0.802 
EAT thickness             1.160 (1.036-1.300) 0.01   
ln EAT volume  2.690 (1.472-4.915) 0.001 1.913 (1.021-3.585) <0.05 
CAD: coronary artery disease; CAC: coronary calcium score; EAT epicardial 
adipose tissue 
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Figure 1 
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